Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Sep 21, 2021
Date Accepted: Feb 24, 2022

The final, peer-reviewed published version of this preprint can be found here:

Privacy, Data Sharing, and Data Security Policies of Women’s mHealth Apps: Scoping Review and Content Analysis

Alfawzan N, Christen M, Spitale G, Biller-Andorno N

Privacy, Data Sharing, and Data Security Policies of Women’s mHealth Apps: Scoping Review and Content Analysis

JMIR Mhealth Uhealth 2022;10(5):e33735

DOI: 10.2196/33735

PMID: 35522465

PMCID: 9123546

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Women’s mHealth Apps: Scoping Review and Content Analysis of Privacy, Data Sharing, and Data Security Policies

  • Najd Alfawzan; 
  • Markus Christen; 
  • Giovanni Spitale; 
  • Nikola Biller-Andorno

ABSTRACT

Background:

Women’s mobile health (mHealth) is a growing phenomenon in the mobile applications (apps) global market. An increasing number of women around the globe use apps with so-called female technology (femtech). Given the often private and sensitive nature of the data collected by such apps an ethical assessment from the perspective of data privacy, sharing, and security policies is warranted.

Objective:

The purpose of this scoping review and content analysis is to assess the privacy policy, data sharing and security policies of women’s mobile health apps current on the international market (AppStore’s on IOS system and GooglePlay’s on Android system).

Methods:

We reviewed 23 most popular women’s mHealth Apps on the market, we focused on publicly available apps on both Apple AppStore and GooglePlay. The 23 downloaded apps were assessed manually by two independent reviewers against mix of users’ data privacy and data sharing and security assessment criteria.

Results:

All of the 23 apps collected personal health-related data. 23 (100%) allowed behavioural tracking and 14 (61%) allowed location tracking. Only 16 apps (69.5%) displayed a privacy policy, and 12 apps (56.5%) requested consent from users, one app had a pseudo-consent. 3 apps collected data before obtaining conscnt. 20 apps (87%) shared users’ data with a third party, and for the remaining 3 apps it is not known if they shared data or not. Only 13 apps (56.5%) provided information to users about data security.

Conclusions:

A large part of the most popular women’s mHealth apps on the market have poor data privacy, sharing, and security standards. Even though regulations exist, such as the EU General Data Protection Regulation (GDPR), current practices do not follow them. The failure standards of the assessed women’s mHealth apps to meet basic data privacy and security is unacceptable both ethically and legally.


 Citation

Please cite as:

Alfawzan N, Christen M, Spitale G, Biller-Andorno N

Privacy, Data Sharing, and Data Security Policies of Women’s mHealth Apps: Scoping Review and Content Analysis

JMIR Mhealth Uhealth 2022;10(5):e33735

DOI: 10.2196/33735

PMID: 35522465

PMCID: 9123546

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.